Latest News and Press Releases

YONKERS, New York, April 02, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of novel,...

THE WOODLANDS, Texas, April 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the...

UK residents will have access to the company's comprehensive, affordable, and professionally monitored home security solutions. BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- SimpliSafe® announced...

NEW HAVEN, Conn., April 02, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company creating a new class of therapies that degrades disease-causing proteins, announced...

TORONTO and OTTAWA, April 02, 2019 (GLOBE NEWSWIRE) -- Internet of Things Inc. (TSX-V: ITT; OTC: INOTF; FSE: 7iT) (“IoT Inc.” or the “Company”), operates data-driven industrial IoT companies that...

TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today...

VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- On Wednesday, April 3, the Fraser Institute will release a new study on Alberta and the Canada Pension Plan. Albertans Make...

TULSA, OK, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AppSwarm, Corp. (OTC: SWRM) announces it has executed a license agreement with M² Farms to utilize the DeliverySwift platform for...

AUSTIN, Texas, April 02, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin...

WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative...